Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Morphea after bromocriptine therapy.

B Leshin1, W W Piette, R M Caplan

  • 1Department of Dermatology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27103.

International Journal of Dermatology
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoid Proteinosis (Lipoglycoproteinosis): A Histochemical Study of Two Cases.

The American journal of pathology·2009
Same author

Endothelial protein C activation in meningococcal sepsis.

The New England journal of medicine·2002
Same author

Cutaneous angiosarcoma.

Advances in dermatology·2002
Same author

Sugaring: an ancient method of hair removal.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2001
Same author

The specialty of the treating physician affects the likelihood of tumor-free resection margins for basal cell carcinoma: results from a multi-institutional retrospective study.

Journal of the American Academy of Dermatology·2001
Same author

Antimalarials.

Dermatologic clinics·2001
Same journal

SENTINOLD and the Challenge of Meaningful Risk Prediction in Melanoma.

International journal of dermatology·2026
Same journal

The "Stamp-n-Tack" Technique: An Ink-Guided Precision Method for Anchoring Tissue After Releasing Facial Retaining Ligaments in Large Facial Flap Reconstruction.

International journal of dermatology·2026
Same journal

Counterfactual Dermatology With Generative Models.

International journal of dermatology·2026
Same journal

Correlation of Clinical and Histopathological Features With Anti-Desmoglein Antibody Profile in Pemphigus Patients.

International journal of dermatology·2026
Same journal

Paracetamol-Induced Generalized Bullous Fixed Drug Eruption With Positive Anti-BP230 Antibody and Confirmed With Oral Provocation Test in a Child: A Case Report From the Philippines.

International journal of dermatology·2026
Same journal

Clinicopathological Challenge: A Painful Violaceous Reticulated Patch.

International journal of dermatology·2026
See all related articles

A patient developed morphea, a fibrotic skin condition, during bromocriptine treatment. This highlights a potential link between bromocriptine and fibrotic disorders, warranting further investigation into drug-induced fibrosis.

Area of Science:

  • Dermatology
  • Pharmacology
  • Pathology

Background:

  • Morphea is a fibrotic skin disorder with various potential etiologies.
  • Certain medications and endogenous compounds have been anecdotally linked to fibrotic conditions.

Observation:

  • A 57-year-old male patient presented with morphea.
  • The patient was concurrently undergoing treatment with bromocriptine, a semisynthetic ergot alkaloid.

Findings:

  • The occurrence of morphea in this patient suggests a potential adverse drug reaction.
  • Bromocriptine belongs to a class of drugs associated with fibrotic disorders, alongside agents like serotonin and beta-adrenergic blockers.

Implications:

  • This case highlights a potential association between bromocriptine use and the development of morphea.

Related Experiment Videos

  • Further research is needed to elucidate the common pathogenic mechanisms linking ergot alkaloids, serotonin, beta-adrenergic blockers, and fibrotic disorders.